LCID
Lucid Group, Inc.
LCID has the edge over OI overall, supported by stronger fundamentals and stronger modeled upside.
OI
O-I Glass, Inc.
OI has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
OI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Weak |
OI's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
OI PE Valuation
OI has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
OI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect OI's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over OI on earnings, with more consistent year-over-year improvement.
OI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.51 | — |
| Q3 2026 | -$7.79 | -$6.87 |
| Q2 2026 | -$7.52 | -$5.89 |
| Q1 2026 | -$1.22 | +$0.02 |
| Q4 2025 | -$0.84 | -$0.15 |
| Q3 2025 | -$0.92 | +$1.76 |
| Q2 2025 | -$1.63 | +$0.21 |
| Q1 2025 | -$1.24 | +$0.27 |
| Q4 2024 | -$0.69 | -$0.02 |
OI lost $7.79 per share over the past year, and its loss has widened in each of the last three quarters.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over OI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
OI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | -1.8% |
| Q2 2026 | $1.7B | -2.2% |
| Q1 2026 | $1.5B | -1.7% |
| Q4 2025 | $1.5B | -1.9% |
| Q3 2025 | $1.7B | -1.5% |
| Q2 2025 | $1.7B | -1.3% |
| Q1 2025 | $1.6B | -1.6% |
| Q4 2024 | $1.5B | -6.8% |
OI's revenue has held roughly level: $1.6B last quarter, down 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.1% | -1.4 points |
| Q2 2026 | -50% | -50 points |
| Q1 2026 | -3.4% | -4.6 points |
| Q4 2025 | -48% | -40 points |
| Q3 2025 | 3.5% | +6.9 points |
| Q2 2025 | 0.4% | -5.6 points |
| Q1 2025 | 1.1% | -6.2 points |
| Q4 2024 | -8.2% | +19 points |
OI has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
OI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $84M | -26% |
| Q2 2026 | -$1M | -102% |
| Q1 2026 | -$436M | -$130M |
| Q4 2025 | $309M | +47% |
| Q3 2025 | $114M | +107% |
| Q2 2025 | $51M | -43% |
| Q1 2025 | -$306M | +$177M |
| Q4 2024 | $210M | +33% |
OI has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
OI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +314K shares |
| 1 year | -0.9% | -1.4M shares |
| 3 years | -3.4% | -5.5M shares |
| 5 years | -4.2% | -6.7M shares |
| Available history | -0.9% | -1.4M shares |
OI has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $10M |
| Q4 2025 | $10M |
| Q3 2025 | $10M |
| Q2 2025 | $10M |
| Q1 2025 | $10M |
| Q4 2024 | $10M |
OI spent $20M buying back its own shares over the past year, down 50% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 10.9x | High |
| Q2 2025 | 14.9x | High |
| Q1 2025 | 11.0x | High |
| Q4 2024 | 8.1x | High |
| Q3 2024 | 20.8x | High |
| Q2 2024 | 12.6x | High |
| Q1 2024 | 11.2x | High |
| Q4 2023 | 7.3x | High |
OI's net debt is about 11 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
OI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.8 | Oversold |
| Stochastic | 5.3 | Oversold |
OI's weekly RSI is 30 (oversold) and its Stochastic is 5 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
OI PE vs Consumer Cyclical Sector
| Metric | OI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
OI has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
OI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.63 | 13% below |
| 20 week MA | $6.90 | 29% below |
| 50 week MA | $10.0 | 51% below |
| 100 week MA | $11.3 | 57% below |
| 200 week MA | $13.9 | 65% below |
OI is in a downtrend: it's below all five of its weekly moving averages, and 65% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
OI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.9 | $11.5 | -3.3% |
| 2021 | $11.5 | $11.5 | +0.3% |
| 2022 | $11.5 | $16.9 | +46% |
| 2023 | $16.9 | $16.4 | -2.9% |
| 2024 | $16.4 | $10.3 | -37% |
| 2025 | $10.3 | $14.9 | +45% |
| 2026 YTD | $14.9 | $4.88 | -67% |
OI has the edge over LCID on returns for 2026, with the stronger performance.